期刊文献+

系统性红斑狼疮患者合并肺动脉高压的临床特点 被引量:3

Clinical study of systemic lupus erythematosus associated pulmonary hypertension
下载PDF
导出
摘要 目的系统性红斑狼疮(SLE)是能够导致患者多脏器损害的自身免疫性疾病,其中肺动脉高压(PH)是严重威胁患者生命的并发症之一。分析SLE患者合并PH的临床特点,讨论PH在SLE患者中发生的影响因素。方法我院就诊的SLE患者,初诊并未经过治疗的患者。回顾性分析100例SLE合并PH患者,并与同期100例无PH的SLE患者进行比较分析。结果 SLE患者合并PH的100例患者年龄14-77岁,平均(33.1±12.3)岁;其中男性8例,女性92例。雷诺现象、间质性肺炎、心包积液和抗心磷脂抗体阳性等因素与SLE患者发生PH呈正相关(P〈0.05)。结论 SLE是自身免疫性疾病合并PH中的较常见疾病,对于出现雷诺现象、间质性肺炎、心包积液和抗心磷脂抗体阳性的SLE患者应警惕发生PH的风险。 Objective Systemic lupus erythematosus(SLE)is an autoimmune disease that has various manifestations and involves virtually all organs. Pulmonary hypertension(PH)is a serious life-threatening complication of SLE.The study is to investigate the clinical manifestations,and the affecting factors of PH in patients with SLE.Methods One hundred SLE patients identified to have concomitant PH by echocardiography were enrolled.The clinical data of 100 patients were analyzed retrospectively.Clinical features,and laboratory data were compared between SLE patients with PH and without PH.Results 100 SLE patients with concomitant PH included 8men and92 women,aged from 14 to 77years,mean age(33.1±12.3)years.Positive correlations were identified between the occurrence of PH and the Raynaud phenomenon,interstitial pneumonia,pericardial effusion,and anti-phospholipid antibody positive(P〈0.05).Conclusion PH is not a rare concomitant disease in SLE patients.The presence of Raynaud phenomenon,interstitial pneumonia,pericardial effusion and anti-phospholipid antibody positivity all suggest the probability of PH in SLE patients.
出处 《临床荟萃》 CAS 2015年第12期1402-1405,共4页 Clinical Focus
关键词 高血压 肺性 红斑狼疮 系统性 雷诺现象 肺疾病 间质性 心包积液 抗心磷脂抗体 hypertension pulmonary lupus erythematosus systemic Raynaud phenomenon pneumonia interstitial pericardial effusion anti-phospholipid antibody
  • 相关文献

参考文献17

  • 1郭惠芳,高丽霞.2014年风湿免疫病学主要临床进展[J].临床荟萃,2015,30(2):167-173. 被引量:7
  • 2Fois E, Le Guern V, Dupuy A,et al. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus retrospective analysis of 93 patients[J]. Clin Exp Rheumatol, 2010, 28(62).. 836-841.
  • 3Dhala A. Pulmonary arterial hypertension in systemic lupus erythematosus: current status and future direction [J]. Clin Dev Immunol, 2012,2012 .. 854941.
  • 4Sasaki N, Kamataki A,Sawai T. A histopathological study of pulmonary hypertension in connective tissue disease [J]. Allergol Int,2011, 60(4): 411-417.
  • 5Johnson SR,Granton JT. Pulmonary hypertension in systemic sclerosis and systemic lupus erythematosus[J]. Eur Respir J, 2011, 20(22), 277-286.
  • 6智淑清,秦毅强,吴晓萍,周晓慧,常永丽,张仲芳.血浆内皮素和抗心磷脂抗体与系统性红斑狼疮并肺动脉高压的相关性研究[J].临床荟萃,2009,24(19):1705-1706. 被引量:2
  • 7Lian F, Chen D, Wang Y, et al. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus[J]. Rheumatol Int, 2012, 32 (6) .. 1727-1731.
  • 8Plazak W, Gryga K, Milewski M, et al. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus[J]. Lupus, 2011, 20(9) : 936-944.
  • 9Cefle A, Inanc M, Sayarlioglu M, et al. Pulmonary hypertension in systemic lupus erythematosus relationship with antiphospholipid antibodies and severe disease outcome [J]. Rheumatol lnt, 2011,31(2): 183-189.
  • 10Kamel SR, Omar GM, Darwish AF, et al. Asymptomatic pulmonary hypertension in systemic lupus erythematosus[J]. Clin Med Insights,2011,4 77-86.

二级参考文献84

  • 1荆志成.2010年中国肺高血压诊治指南[J].中国医学前沿杂志(电子版),2011,3(2):62-81. 被引量:118
  • 2郭丽苹,薛炜.右心构型无改变SLE患者肺动脉血流的超声检测价值[J].中国超声诊断杂志,2004,5(10):736-738. 被引量:5
  • 3Pan TL, Thumboo J, Boey ML. Primary and secondary pulmonary hypertension in systemic lupus erythematosus[J]. Lupus, 2000,9(5):338-342.
  • 4Inoue A,Yanagisawa M,Kimura S,et al. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes[J]. Proc Natl Acad Sol USA,1989,86(8) :2863 -2867.
  • 5Pierangeli SS, Harris EN. Clinical laboratory testing for the antiphospholipid syndrom[J]. Clin Chim Acta, 2005,357 ( 1 ) : 17- 33.
  • 6Varga J. Pulmonary hypertension in systemic sclerosis: bete noire no more? [J]. Curr Opin Rheumatol,2002,14(6):666- 670.
  • 7Shi-Wen X,Denton CP, Dashwood MR, et al. Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1[J]. J Invest Dermatol,2001,116(3) :417-425.
  • 8Alarcon-Segovia D, Deleze M, Oria CV, et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythenmtosus. A prospective analysis of 500 consecutive patients[J]. Medicine(Baltimore), 1989,68(6) :353-365.
  • 9Hanly JG. Antiphospholipid syndrome, an overview[J]. CMAJ, 2003 168 (13):1675-1682.
  • 10Cuadrado MJ, Lopez- Pedrera C. Antiphospholipid syndrome[J]. Clin Exp Med,2003,3(3) :129-139.

共引文献11

同被引文献42

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部